Accord Healthcare AG - Posaconazol Accord 100 mg, magensaftresistente Tablette | | 67363 | | 01 | | Posaconazol Accord 100 mg | | magensaftresistente Tablette | | J02AC04 | | Posaconazole | | 19.12.2019 | | |
| Composition | posaconazolum 100 mg, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, xylitolum, hydroxypropylcellulosum, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum, natrii stearylis fumaras, E 310, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 1.25 mg. | Packungsbestandteile | | Comprimés résistants au suc gastrique | | | Principe actif | Concentr. |
---|
Posaconazole | 100 mg |
| BAG: Principe actif | Concentr. |
---|
Posaconazole | 100 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | Acidi Methacrylici | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | E 310 | | | Ethylis Acrylatis Polymerisatum | | | Hydroxypropylcellulosum | | | Macrogol | 3350 | | Natrii Stearylis Fumaras | | | Poly(Alcohol Vinylicus) | | Überzug | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | | Triethylis Citras | | | Xylitol | | |
| |
| |
|